Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Patients Pfs'

Patients Pfs published presentations and documents on DocSlides.

Median PFS: 2.6 months (95% CI, 1.7-3.5)

Median PFS: 2.6 months (95% CI, 1.7-3.5)

  • ceila
  • 5 Slides

Median PFS: 1.4 months (95% CI, 1.2-1.6) . Median ...

Blinded Sample Size Re-estimation in a Phase III Study Inve

Blinded Sample Size Re-estimation in a Phase III Study Inve

  • luanne-stotts
  • 27 Slides

David Morgan (King’s College, London / Consulta...

Btk inhibition in Mantle cell Lymphoma & CLL

Btk inhibition in Mantle cell Lymphoma & CLL

  • test
  • 0 Slides

Simon Rule. Professor of Clinical . Haematology. ...

Nouveautés dans le CBNPC métastatique

Nouveautés dans le CBNPC métastatique

  • vizettan
  • 98 Slides

Celine Mascaux, MD, . PhD. Multidisciplinary . Onc...

2022 Spring Oncology Conference

2022 Spring Oncology Conference

  • byrne
  • 62 Slides

Evolving Treatment Strategies. for CLL/SLL and MCL...

ESMO 2021 (Virtual) Congress Report

ESMO 2021 (Virtual) Congress Report

  • SnuggleBug
  • 122 Slides

Lung and gastrointestinal cancers. Slide numbers. ...

Blinded Sample Size Re-estimation in a Phase III Study Investigating Progression Free Survival

Blinded Sample Size Re-estimation in a Phase III Study Investigating Progression Free Survival

  • naomi
  • 27 Slides

David Morgan (King’s College, London / Consultan...

YIR On Demand Lung Benjamin Levy, MD 

YIR On Demand Lung Benjamin Levy, MD 

  • jovita
  • 84 Slides

Assistant Professor. Johns Hopkins School of Medic...

Her-2 negative MBC

Her-2 negative MBC

  • conchita-marotz
  • 47 Slides

10/25/2016. Objectives. General principles. Endoc...

BELLE-3: A Phase III Study of

BELLE-3: A Phase III Study of

  • faustina-dinatale
  • 0 Slides

Buparlisib. and . Fulvestrant. in Postmenopausa...

Managing Advanced Renal Cell

Managing Advanced Renal Cell

  • debby-jeon
  • 0 Slides

Carcinoma: Balancing . Efficacy with Quality of L...

Update on Diagnosis and Treatments

Update on Diagnosis and Treatments

  • joanne
  • 29 Slides

of Multiple Myeloma. Kenneth C. Anderson, M.D.. J...

Considerations for Optimizing Transplant in Multiple Myeloma Patient Management

Considerations for Optimizing Transplant in Multiple Myeloma Patient Management

  • TravelingSoulmate
  • 77 Slides

PARAMESWARAN HARI MD. MEDICAL COLLEGE OF WISCONSIN...

Summary 2011 Founded 2010

Summary 2011 Founded 2010

  • eliza
  • 13 Slides

in Houston. Vision: To be the leader in the develo...

Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone in Relapsed or Ref

Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone in Relapsed or Ref

  • willow
  • 15 Slides

Meletios Dimopoulos,. 1. Hang Quach,. 2. Maria-V...

Concomitant administration of palbociclib and proton pump inhibitors affects clinical outcomes in m

Concomitant administration of palbociclib and proton pump inhibitors affects clinical outcomes in m

  • felicity
  • 1 Slides

Cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor...

Beyond Secret Handshakes:

Beyond Secret Handshakes:

  • pasty-toler
  • 31 Slides

Affiliation-Hiding Authenticated Key Exchange. Fr...

2014 Oklahoma Business Summit

2014 Oklahoma Business Summit

  • marina-yarberry
  • 10 Slides

Sarah Roberts, Inasmuch Foundation, Program Offic...

Thierry Le Chevalier, MD

Thierry Le Chevalier, MD

  • yoshiko-marsland
  • 55 Slides

How . d. o International Regulatory Groups View C...

Partnerships for Success

Partnerships for Success

  • test
  • 28 Slides

Creating Positive School Experiences And Develop...

Ray Jones

Ray Jones

  • danika-pritchard
  • 37 Slides

Director of Solutions Architecture and Field Enab...

Thierry Le Chevalier, MD

Thierry Le Chevalier, MD

  • aaron
  • 53 Slides

How . d. o . International Regulatory Groups View...

Applying “Pay for Success” Social Impact Finance to Ear

Applying “Pay for Success” Social Impact Finance to Ear

  • luanne-stotts
  • 16 Slides

Janis Dubno, Voices for Utah Children. Andrea Phi...

Interpretation of the Great Plains Polygonal Fault

Interpretation of the Great Plains Polygonal Fault

  • luanne-stotts
  • 0 Slides

Andy St-Onge, Calgary geophysicist@shaw.ca. (i) S...

Jointly provided by & This activity is supported by educations grants from Novartis Pharmaceuticals Corporation, Pfizer, and Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com

Jointly provided by & This activity is supported by educations grants from Novartis Pharmaceuticals Corporation, Pfizer, and Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com

  • olivia-moreira
  • 67 Slides

Jointly provided by ...

End-points utilized in

End-points utilized in

  • marina-yarberry
  • 10 Slides

End-points utilized in breast cancer clinical ...

Game Plan Trends in ovarian cancer

Game Plan Trends in ovarian cancer

  • alexa-scheidler
  • 59 Slides

Diagnostic work-up. Treatment. The most commonly ...

Presentation

Presentation

  • wang
  • 1 Slides

pfs-full-vlSchema Taxo Fullwith capitalpfs-fullPre...

End-points utilized in breast cancer

End-points utilized in breast cancer

  • evelyn
  • 10 Slides

clinical . trials - Discussion. Novartis Oncology...

Pay for Success: Innovative Financing to Improve Child Outcomes

Pay for Success: Innovative Financing to Improve Child Outcomes

  • dominic513
  • 20 Slides

Jennifer Tschantz; Early Childhood Research to Pra...

Update on transplant-ineligible patients:

Update on transplant-ineligible patients:

  • trish-goza
  • 34 Slides

Which . regimens are best?. Suzanne Lentzsch MD, ...

iJOURNAL CLUB: Optimizing Therapy for Patients with Metastatic Squamous Cell Carcinoma of the Lung

iJOURNAL CLUB: Optimizing Therapy for Patients with Metastatic Squamous Cell Carcinoma of the Lung

  • berey
  • 45 Slides

Interview with Shirish M . Gadgeel. , MD . January...

Impact of Imatinib interruption & duration of prior Hyd

Impact of Imatinib interruption & duration of prior Hyd

  • pamella-moone
  • 21 Slides

Raafat. R. Abdel-. Malek. , MD, FRCR. Ass. Prof ...

Department of GI Medical Oncology

Department of GI Medical Oncology

  • danika-pritchard
  • 38 Slides

Does . the New EPOC trial . eliminate. . Anti. -...

Thierry

Thierry

  • cheryl-pisano
  • 40 Slides

Le Chevalier, . MD. The Role of Translational Res...

Novel

Novel

  • tatiana-dople
  • 28 Slides

Agents . for . Indolent . L. ymphoma . and . Mant...

ASCO 2010:

ASCO 2010:

  • phoebe-click
  • 75 Slides

. Highlights from the Annual Clinical Meeting. G...

17th Annual International Congress

17th Annual International Congress

  • conchita-marotz
  • 108 Slides

on . Hematologic Malignancies. ®. : . Focus . on...

Immunotherapy for

Immunotherapy for

  • sherrill-nordquist
  • 37 Slides

High-Risk and Metastatic Melanoma. Timothy M. Kuz...

Where we are with targeted

Where we are with targeted

  • stefany-barnette
  • 32 Slides

therapies . for . cholangiocarcinoma. Professor J...

Copyright © 2024 DocSlides. All Rights Reserved